ARCHIVES

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

Broder Not Satisfied With Mortality STATS On Three Major Cancers

September 20, 1991

In Brief: Senate Markup adds $22 Mil. To NCI Budget; Roper formally Named NCI Deputy Director

September 22, 1989

Conversation with The Cancer Letter: Is Republican Control Better Than Two-Party Stalemate?

December 19, 2014

In Brief: Robert McKenna Named New President Of Society Of Surgical Oncology, Hiram Polk President Elect

May 13, 1983

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014